Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06548776 · ClinicalTrials.gov registry record · NA
Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord
A NA study of Spinal Cord, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT06548776: Recruiting NA study of Spinal Cord, sponsored by M.D. Anderson Cancer Center.
NCT06548776 is a NA study of Spinal Cord that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06548776, a NA study of Spinal Cord, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if MRS can effectively assess spinal cord lesions.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Magnetic Resonance Spectroscopy (MRS) Scan
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2024-09-04 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT06548776 shows while recruiting
NCT06548776 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Spinal Cord appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Resonance Spectroscopy (MRS) Scan is the first listed.
NCT06548776 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06548776 about?
NCT06548776 is a clinical study titled "Establishing Daily Applicable Parameters for Using Magnetic Resonance Spectroscopy of Spinal Cord". To learn if MRS can effectively assess spinal cord lesions.
What is the current status of trial NCT06548776?
This trial is currently recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2024-09-04. Estimated completion is 2028-07-31.
What conditions does trial NCT06548776 study?
This clinical trial studies the following conditions: Spinal Cord.
What interventions are being tested in trial NCT06548776?
The interventions under investigation include: Magnetic Resonance Spectroscopy (MRS) Scan (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06548776?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06548776 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06548776's enrollment target sits among peer trials
13 1912th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI